Infection Control News

After a sharp increase in global malaria cases and deaths as COVID-19 spread in 2020, WHO reported that both cases and deaths remained relatively stable in 2021.

Pfizer recently announced that its respiratory syncytial vaccine candidate for older adults, RSVpreF, was granted priority review by the FDA.

The incidence of myopericarditis among adolescents and young adults who received mRNA COVID-19 vaccines is very low, according to a systemic review and meta-analysis published in JAMA Pediatrics.

The FDA on Thursday expanded its emergency use authorization of Moderna and Pfizer-BioNTech’s omicron-targeting bivalent COVID-19 boosters to include children aged as young as 6 months in the United States.

The FDA has granted priority review to a biologics license application for Pfizer’s respiratory syncytial virus vaccine candidate, RSVpreF, for older adults, according to the company.

An expert in influenza is encouraging the public to get vaccinated ahead of “a tough season” during National Influenza Vaccination Week.

A nationally representative study demonstrated a wide geographic variation in influenza vaccination for both non-Hispanic white and Hispanic short-stay and long-stay nursing home residents.

Pfizer and BioNTech are seeking an emergency use authorization from the FDA for omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines in children aged 6 months to 4 years.

Last week, WHO announced that it will begin using the term “mpox” for monkeypox disease to avoid stigmatizing language.

WASHINGTON — A leading expert in hepatology called for fellow specialists to embrace a role of education, advocacy and support as part of a proposed national hepatitis C virus elimination program presented during The Liver Meeting.